Nature Reviews Urology

Papers
(The TQCC of Nature Reviews Urology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything214
Texture analysis for patient selection195
Single-cell and spatial sequencing of kidney cancer143
Human-relevant urothelial model provides insight into infection strategies and host response128
Krause corpuscles act as genital vibration detectors99
Semen quality recovery following COVID-1997
PARP inhibitors plus enzalutamide to treat mCRPC81
Urine microbiota differ in bladder cancer78
Preclinical models of bladder cancer: BBN and beyond76
Micro-ultrasound for prostate cancer75
High-dose chemotherapy for relapsed testicular germ cell tumours72
Time for women-centred gynaecology71
Advancing the state of the art in congenital obstructive uropathy69
Considering urology in a planetary context65
Proteomic-based analysis of testicular interstitial fluid64
A clinical guide to rare male sexual disorders64
FOXA2–KIT-driven lineage plasticity in NEPC64
Prevalence of gender dysphoria in Japan59
A new text message-based platform for self-management of patients with IC/BPS56
Overcoming antibiotic resistance in complicated UTI53
Promise without practice — charting the path forward for bladder cancer biomarkers53
Madrid plays host to a celebration of urology51
Metaverse in surgery — origins and future potential51
Microfluidic sperm selection50
What happens in Vegas … shapes the future of urology50
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations49
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers49
Evolution of the World Health Organization semen analysis manual: where are we?48
Leveraging generative AI to enhance doctor–patient communication48
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer46
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence46
Pembrolizumab + axitinib beyond first-line therapy for mRCC46
A non-invasive assay for UTUC diagnosis45
COVID can’t kill CopMich collaboration44
Vaccination to prevent untreatable gonorrhoea42
The mechanism of action of neuromodulation in the treatment of overactive bladder42
Measuring and improving the cradle-to-grave environmental performance of urological procedures42
Resolving the puzzle of same-sex sexual interactions39
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications39
Efficacy of the Revi system in treating urgency urinary incontinence38
PEACEing together prostate cancer therapy38
Personalized 3D models for prostate cancer surgery37
EMUC25: shaping tomorrow’s uro-oncology care36
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment36
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway34
Sexual orientation, gender identity and COVID: a complicated picture33
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility33
Effect of high glucose on E. coli32
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC31
The magic of MagSToNE30
Secondary kidney stones — remove or leave?29
Cribriform morphology affects mpMRI imaging29
A distinct TAM subset mediates immunotherapy resistance in prostate cancer28
Women in urology: the past28
Promising efficacy of UTI vaccines as an alternative to antibiotics27
AUA returns to its former glory in Chicago27
Prostate cancer in transgender women — challenges in research and clinical care26
Microultrasonography-guided prostate cancer biopsy25
Robots learning to imitate surgeons — challenges and possibilities25
Successful mentorship for women in urology — a new era24
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards24
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective24
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease23
Technical modifications to improve erectile function recovery after radical prostatectomy23
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?23
A clinical overview of people living with HIV and genitourinary cancer care22
Videourodynamics — role, benefits and optimal practice22
Current and emerging strategies to curb antibiotic-resistant urinary tract infections22
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer22
Is it time to rethink the current patient-reported outcome measures?22
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer21
Management and cost of stent encrustation in pregnancy21
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer21
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health19
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD19
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning19
Pride, not prejudice18
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures18
AI for antibiotic design18
Androgen receptor pathway inhibitor combination in prostate cancer16
Turning up the heat: CTLA4 blockade in urothelial cancer16
De-clear cell differentiated renal cell carcinoma — a new therapeutic target16
The future of patient-derived xenografts in prostate cancer research16
Turning back time in the testes15
The prognostic role of stroma in UTUC15
Uncovering a link between COVID-19 and renal cell carcinoma15
The evolving treatment landscape of metastatic urothelial cancer15
The value of women urologists — individual and institutional imperatives to address salary equity15
Immune-based therapies in penile cancer15
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy14
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself14
Urinary tract infections in children13
The shifting treatment paradigm of metastatic renal cell carcinoma13
Current and future pharmacotherapy for female sexual dysfunction13
We all get erections — de-gendering sexual arousal dysfunction in the ICD13
Och AI the noo from SIU13
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer12
Improved phenotypic classification of male infertility to promote discovery of genetic causes12
Pelvic-fascia-sparing techniques and outcomes with RARP12
Hallmark discoveries in the biology of Wilms tumour12
Effects of COVID-19 vaccine on semen parameters11
Men hold the balance of power11
CMA mediates resistance to androgen inhibitors in prostate cancer11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome11
Power up to investigate PrEP11
The unclear role of PET–CT in localized radiorecurrent prostate cancer11
Tuft cells in prostate cancer10
Mellow yellow: BilR reduces bilirubin to urobilinogen10
Spatiotemporal trends in human semen quality10
Metabolism, mitochondria and metastasis in kidney cancer10
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer10
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications10
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI10
BAUSing back in Birmingham10
Diagnosis of ccRCC10
Male infertility and somatic health — insights into lipid damage as a mechanistic link10
Mechanisms of the intestinal and urinary microbiome in kidney stone disease10
Pronouns in English: a user’s guide9
Sperm activity affected by endometriosis9
Stepping up to prevent bacterial vaginosis recurrence9
Semen parameters across testicular cancer stages9
Chlorination by-products in drinking water — association with bladder cancer risk9
Syphilis on the rise — a need for alternative therapies and vaccines9
MRI diagnosis and radical prostatectomy outcomes9
Testosterone replacement therapy and spermatogenesis in reproductive age men9
Advances in sliding clip renorrhaphy for partial nephrectomy9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS8
Visual clues — dermatological manifestations of sexually transmitted infections in men8
Particulate matter leaves a bitter taste in testes8
A great gathering at the 4th Clinical and Scientific Advances in UTI conference8
Urology on a changing planet: links between climate change and urological disease8
The ins and outs of penile erection8
Smooth muscle cell plasticity in pelvic organ prolapse8
Artificial intelligence in the management of prostate cancer8
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma7
Clinical trial design for non-muscle-invasive bladder cancer7
The future of pelvic lymph node dissection for urological malignancies7
The effects of diet on prostate cancer outcomes7
Influence of substance use on male reproductive health and offspring outcomes7
Feasibility and potential of an MRI-based prostate cancer screening7
ADT intensification to treat biochemically recurrent prostate cancer7
Genetic and biological drivers of prostate cancer disparities in Black men7
EAU26: innovation, patient care and a touch of mythology7
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning7
Prescribing clinician specialty influences adherence to PrEP7
0.13010478019714